Literature DB >> 8504456

[Serum cholesterol and cancer mortality: eleven-year prospective cohort study on more than nine thousand persons].

W X Li1.   

Abstract

Nine thousand and twenty-one employees aged 35-64 years were investigated in the 70s in the meantime with serum cholesterol and other measurements taken, and followed up for 11 years on the average. There were 595 deaths and 64 loss of follow-up. The total number of cancer death was 263 that of primary liver cancer was 51. Subjects were divided into 4 similar sized groups according to serum cholesterol level at basal measurement. No evidence of association of serum cholesterol level with total cancer mortality was seen by Log-rank trend test. But negative correlation was significant between serum cholesterol level and liver cancer (P < 0.05). By Cox regression analysis such negative correlation was found to be independent of other variables (Z = -2.18, P < 0.05). This negative correlation persisted even after 14 deaths of primary liver cancer which occurred within 3 years after measurement of serum cholesterol was discounted. Similar negative correlation also existed between serum cholesterol level and chronic hepatitis and liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8504456

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  3 in total

1.  Pro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells.

Authors:  Mingyan He; Wenhui Zhang; Yinying Dong; Lishun Wang; Tingting Fang; Wenqing Tang; Bei Lv; Guanglang Chen; Biwei Yang; Peixin Huang; Jinglin Xia
Journal:  J Exp Clin Cancer Res       Date:  2017-01-18

Review 2.  Influence of liver cancer on lipid and lipoprotein metabolism.

Authors:  Jingting Jiang; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2006-03-03       Impact factor: 3.876

Review 3.  From Liver Fat to Cancer: Perils of the Western Diet.

Authors:  Ju Youn Kim; Feng He; Michael Karin
Journal:  Cancers (Basel)       Date:  2021-03-04       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.